Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4796636 | 0.78 | TLR7 (0.45) | — | |
| SCHEMBL2087126 | 0.78 | TLR7 (0.45) | — | |
| SCHEMBL2087054 | 0.76 | MPO (0.30) | MPO | |
| SCHEMBL203276 | 0.71 | CYP3A4 (0.36) | — | |
| SCHEMBL203764 | 0.71 | CYP3A4 (0.36) | — | |
| SCHEMBL1773860 | 0.69 | KDM4E (0.34) | — | |
| SCHEMBL202597 | 0.69 | KDM4E (0.37) | LRRK2 | |
| SCHEMBL18606495 | 0.68 | LRRK2 (0.57) | LRRK2 | |
| SCHEMBL18606496 | 0.68 | LRRK2 (0.57) | LRRK2 | |
| SCHEMBL30155001 | 0.67 | LRRK2 (0.60) | LRRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7906506-B2 | Immunomodulators, inducing cytokine biosynthesis in animals; antiviral agents, antitumor agents; e.g. (11S)-1-Methyl-8-propyl-10,11-dihydro-8H-[1,4]oxazino[4',3':1,2]imidazo[4,5-c]quinolin-6-amine | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-03-15 | — | — | US | disclosed |
| US-20080070907-A1 | Substituted chiral fused [1,2] imidazo [4,5-C] ring compounds and methods | COLEY PHARMACEUTICAL GROUP, INC. (US) | 2008-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080070907-A1 | Substituted chiral fused [1,2] imidazo [4,5-C] ring compounds and methods | IFNAR1, IL2, IFNG | LRRK2 3310/4885MPO 2360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.